{"url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764732/", "query": "alkaline water cancer cure -healthline", "actual-search-type": "n", "expected-search-type": "a", "contents": "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n<!DOCTYPE html PUBLIC \"-//W3C//DTD XHTML 1.0 Transitional//EN\" \"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd\">\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\">\n    \n    <head><meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n        <!-- AppResources meta begin -->\n        <script type=\"text/javascript\">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name=\"paf_template\" content=\"\" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name=\"ncbi_db\" content=\"pmc\" /><meta name=\"ncbi_pdid\" content=\"article\" /><meta name=\"ncbi_acc\" content=\"\" /><meta name=\"ncbi_domain\" content=\"ijmedpaed\" /><meta name=\"ncbi_report\" content=\"record\" /><meta name=\"ncbi_type\" content=\"fulltext\" /><meta name=\"ncbi_objectid\" content=\"\" /><meta name=\"ncbi_pcid\" content=\"/articles/PMC3764732/\" /><meta name=\"ncbi_app\" content=\"pmc\" />\n        <!-- Logger end -->\n        \n        <title>Stage IV lung cancer: Is cure possible?</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel=\"stylesheet\" href=\"/core/jig/1.14.8/css/jig.min.css\" /><script type=\"text/javascript\" src=\"/core/jig/1.14.8/js/jig.min.js\"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name=\"robots\" content=\"INDEX,NOFOLLOW,NOARCHIVE\" /><link rel=\"canonical\" href=\"/pmc/articles/PMC3764732/\" /><link rel=\"schema.DC\" href=\"http://purl.org/DC/elements/1.0/\" /><meta name=\"citation_journal_title\" content=\"Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical &amp; Paediatric Oncology\" /><meta name=\"citation_title\" content=\"Stage IV lung cancer: Is cure possible?\" /><meta name=\"citation_authors\" content=\"Ravi Thippeswamy, Vanita Noronha, Vamshi Krishna, Amit Joshi, Munita Meenu Bal, Nilendu Purandare, V. Rangarajan, C. S. Pramesh, Sabita Jiwnani, Kumar Prabhash\" /><meta name=\"citation_date\" content=\"Apr-Jun 2013\" /><meta name=\"citation_issue\" content=\"2\" /><meta name=\"citation_volume\" content=\"34\" /><meta name=\"citation_firstpage\" content=\"121\" /><meta name=\"citation_doi\" content=\"10.4103/0971-5851.116207\" /><meta name=\"citation_abstract_html_url\" content=\"/pmc/articles/PMC3764732/?report=abstract\" /><meta name=\"citation_pmid\" content=\"24049303\" /><meta name=\"DC.Title\" content=\"Stage IV lung cancer: Is cure possible?\" /><meta name=\"DC.Type\" content=\"Text\" /><meta name=\"DC.Publisher\" content=\"Medknow Publications\" /><meta name=\"DC.Contributor\" content=\"Ravi Thippeswamy\" /><meta name=\"DC.Contributor\" content=\"Vanita Noronha\" /><meta name=\"DC.Contributor\" content=\"Vamshi Krishna\" /><meta name=\"DC.Contributor\" content=\"Amit Joshi\" /><meta name=\"DC.Contributor\" content=\"Munita Meenu Bal\" /><meta name=\"DC.Contributor\" content=\"Nilendu Purandare\" /><meta name=\"DC.Contributor\" content=\"V. Rangarajan\" /><meta name=\"DC.Contributor\" content=\"C. S. Pramesh\" /><meta name=\"DC.Contributor\" content=\"Sabita Jiwnani\" /><meta name=\"DC.Contributor\" content=\"Kumar Prabhash\" /><meta name=\"DC.Date\" content=\"Apr-Jun 2013\" /><meta name=\"DC.Identifier\" content=\"10.4103/0971-5851.116207\" /><meta name=\"DC.Language\" content=\"en\" /><meta property=\"og:title\" content=\"Stage IV lung cancer: Is cure possible?\" /><meta property=\"og:type\" content=\"article\" /><meta property=\"og:description\" content=\"Reporting a case, 53 years old male with stage IV Nonsamall cell lung cancer in view of cytologically proven malignant pleural effusion. Usually the management of stage IV lung cancer is with palliative intent where the patient receives palliative chemotherapy ...\" /><meta property=\"og:url\" content=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764732/\" /><meta property=\"og:site_name\" content=\"PubMed Central (PMC)\" /><meta property=\"og:image\" content=\"https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png\" /><meta name=\"twitter:card\" content=\"summary\" /><meta name=\"twitter:site\" content=\"@ncbi\" /><link rel=\"stylesheet\" href=\"/corehtml/pmc/css/3.6/pmc.min.css\" type=\"text/css\" /><link rel=\"stylesheet\" href=\"/corehtml/pmc/css/3.6/pmc_extras_prnt.min.css\" type=\"text/css\" media=\"print\" /><script type=\"text/javascript\" src=\"/corehtml/pmc/js/common.min.js\">//</script><script type=\"text/javascript\" src=\"/corehtml/pmc/js/NcbiTagServer.min.js\">//</script><meta name=\"citationexporter\" content=\"backend:'/pmc/utils/ctxp/'\" /><script type=\"text/javascript\" src=\"/corehtml/pmc/ctxp/jquery.citationexporter.js\">//</script><link rel=\"stylesheet\" href=\"/corehtml/pmc/ctxp/citationexporter.css\" type=\"text/css\" /><script type=\"text/javascript\" src=\"/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js\"></script><script type=\"text/javascript\" src=\"/corehtml/pmc/js/large-obj-scrollbars.min.js\"></script><script type=\"text/javascript\">window.name=\"mainwindow\";</script><style type=\"text/css\">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-ijmedpaed.gif);background-size: auto, contain}</style><style type=\"text/css\">.print-view{display:block}</style><style type=\"text/css\">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name=\"cited_in_systematic_reviews\" content=\"\" /><link rel=\"alternate\" type=\"application/epub+zip\" href=\"/pmc/articles/PMC3764732/epub/\" />\n\n        <!-- Page meta end -->\n    <link rel=\"shortcut icon\" href=\"//www.ncbi.nlm.nih.gov/favicon.ico\" /><meta name=\"ncbi_phid\" content=\"8A1A37C181F4D4C100000000005F005D\" /><link type=\"text/css\" rel=\"stylesheet\" href=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4120508/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4052581/9685/3549676/3609192/3609193/3609213/3395586/3855312.css\" /><link type=\"text/css\" rel=\"stylesheet\" href=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/css/3411343/3882866/3929378.css\" media=\"print\" /></head>\n    <body class=\"article\">\n        <div class=\"grid\">\n            <div class=\"col twelve_col nomargin shadow\">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class=\"sysmessages\">\n                    <noscript>\n\t<p class=\"nojs\">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href=\"/guide/browsers/#enablejs\" title=\"Learn how to enable JavaScript\" target=\"_blank\">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class=\"wrap\">\n                    <div class=\"page\">\n                        <div class=\"top\">\n                            <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a class=\"ui-ncbimenu-link-first\" href=\"/\" role=\"banner\" title=\"NCBI Home\" id=\"ncbihome\" accesskey=\"1\"><span class=\"offscreen_noflow\">NCBI</span><img src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/img/28977\" class=\"ncbi_logo\" title=\"NCBI\" alt=\"NCBI Logo\" /></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a href=\"#maincontent\" title=\"Skip to the content\" tabindex=\"0\" accesskey=\"3\">Skip to main\n                        content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a href=\"#navcontent\" title=\"Skip to the navigation\" tabindex=\"0\" accesskey=\"4\">Skip to\n                        navigation</a></li><li id=\"resource-menu\" class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li id=\"all-howtos-menu\" class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a href=\"/guide/browsers/#accesskeys\" title=\"About My NCBI Accesskeys\" tabindex=\"0\" accesskey=\"0\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n                            <div class=\"header\">\n    <div class=\"res_logo\">\n  <h1 class=\"img_logo\"><a href=\"/pmc/\" class=\"pmc_logo offscreen\">PMC</a></h1>\n  <div class=\"NLMLogo\">\n    <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n    <br />\n    <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n  </div>\n</div>\n    <div class=\"search\"><form method=\"get\" action=\"/pmc/\"><div class=\"search_form\"><label for=\"database\" class=\"offscreen_noflow\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option value=\"pmc\" selected=\"selected\" class=\"last\" data-ac_dict=\"pmc-search-autocomplete\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"clone\">Clone</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"nucest\">EST</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"nucgss\">GSS</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option value=\"pmc\" data-ac_dict=\"pmc-search-autocomplete\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"pubmedhealth\">PubMed Health</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbook\">ToolKitBook</option><option value=\"toolkitbookgh\">ToolKitBookgh</option><option value=\"unigene\">UniGene</option></optgroup></select><div class=\"nowrap\"><label for=\"term\" class=\"offscreen_noflow\" accesskey=\"/\">Search term</label><div class=\"nowrap\"><input type=\"text\" name=\"term\" id=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" value=\"\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" autocomplete=\"off\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" /></div><button id=\"search\" type=\"submit\" class=\"button_search nowrap\" cmd=\"go\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n                        <a href=\"/pmc/advanced/\">Advanced</a>\n                    </li><li>\n                        <a href=\"/pmc/journals/\">Journal list</a>\n                    </li><li class=\"help\">\n                        <a target=\"_blank\" href=\"/books/NBK3825/\">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id=\"Page\" label=\"headcontent\"/>-->\n                            \n                        </div>\n                        <div class=\"content\">\n                            <!-- site messages -->\n                            <div class=\"container\">\n    <div id=\"maincontent\" class=\"content eight_col col\">\n        <div class=\"navlink-box\">\n            <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a href=\"/pmc/journals/\" class=\"navlink\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1247/\">Indian J Med Paediatr Oncol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/227223/\">v.34(2); Apr-Jun 2013</a></li><li class=\"accid\">PMC3764732</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class=\"pmc-page-banner whole_rhythm\"><div><img src=\"/corehtml/pmc/pmcgifs/logo-ijmedpaed.gif\" alt=\"Logo of ijmedpaed\" usemap=\"#logo-imagemap\" /><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area shape=\"poly\" coords=\"0,0,500,0,500,21,400,21,400,75,0,75\" alt=\"Home\" title=\"Home\" href=\"http://www.ijmpo.org/\" ref=\"reftype=publisher&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal\" target=\"pmc_ext\" /><area shape=\"rect\" coords=\"410,24,500,37\" alt=\"Current issue\" title=\"Current issue\" href=\"http://www.ijmpo.org/currentissue.asp\" ref=\"reftype=publisher&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal\" target=\"pmc_ext\" /><area shape=\"rect\" coords=\"410,42,500,53\" alt=\"Instructions\" title=\"Instructions\" href=\"http://www.ijmpo.org/contributors.asp\" ref=\"reftype=publisher&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal\" target=\"pmc_ext\" /><area shape=\"rect\" coords=\"410,59,500,75\" alt=\"Submit article\" title=\"Submit article\" href=\"http://www.journalonweb.com/ijmpo\" ref=\"reftype=publisher&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal\" target=\"pmc_ext\" /></map></div> </div>\n        \n        <!--component id='MainPortlet' label='search-reference'/-->\n        \n        <!-- Book content -->\n        <div class=\"\">\n            \n        \n            \n            <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"small\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Indian J Med Paediatr Oncol</span>. 2013 Apr-Jun; 34(2): 121\u2013125. </span></div><div>  <span class=\"doi\">doi:\u00a0 <a href=\"//dx.doi.org/10.4103%2F0971-5851.116207\" target=\"pmc_ext\" ref=\"reftype=other&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal\">10.4103/0971-5851.116207</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC3764732</span></div></div></div></div></div><h1 class=\"content-title\">Stage IV lung cancer: Is cure possible?</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a href=\"/pubmed/?term=Thippeswamy%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Ravi Thippeswamy</a>,<sup></sup> <a href=\"/pubmed/?term=Noronha%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Vanita Noronha</a>,<sup></sup> <a href=\"/pubmed/?term=Krishna%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Vamshi Krishna</a>,<sup></sup> <a href=\"/pubmed/?term=Joshi%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Amit Joshi</a>,<sup></sup> <a href=\"/pubmed/?term=Bal%20MM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Munita Meenu Bal</a>,<sup>1</sup> <a href=\"/pubmed/?term=Purandare%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Nilendu Purandare</a>,<sup>2</sup> <a href=\"/pubmed/?term=Rangarajan%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">V. Rangarajan</a>,<sup>2</sup> <a href=\"/pubmed/?term=Pramesh%20CS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">C. S. Pramesh</a>,<sup>3</sup> <a href=\"/pubmed/?term=Jiwnani%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Sabita Jiwnani</a>,<sup>3</sup> and  <a href=\"/pubmed/?term=Prabhash%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24049303\">Kumar Prabhash</a><sup></sup><sup></sup></div></div><div class=\"fm-panel small half_rhythm\"><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"id864920_ai\" style=\"display:none\"><div class=\"fm-affl\" lang=\"en\"><em>Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India</em></div><div class=\"fm-affl\" lang=\"en\"><sup>1</sup><em>Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India</em></div><div class=\"fm-affl\" lang=\"en\"><sup>2</sup><em>Department of Nuclear Medicine, Tata Memorial Hospital, Mumbai, Maharashtra, India</em></div><div class=\"fm-affl\" lang=\"en\"><sup>3</sup><em>Thoracic Services, Tata Memorial Hospital, Mumbai, Maharashtra, India</em></div><div id=\"cor1\"><strong>Address for correspondence:</strong> Dr. Kumar Prabhash, Room No 18, Main Building, Department of Medical Oncology, Tata Memorial Hospital Parel, Mumbai, Maharashtra - 400012, India. E-mail: <a href=\"mailto:dev@null\" data-email=\"moc.liamg@1hsahbarpk\" class=\"oemail\">moc.liamg@1hsahbarpk</a></div></div><div class=\"togglers\"><a href=\"#\" class=\"pmctoggle\" rid=\"id864920_ai\">Author information <span>\u25ba</span></a> <a href=\"#\" class=\"pmctoggle\" rid=\"id864920_cpl\">Copyright and License information <span>\u25ba</span></a></div><div class=\"fm-article-notes fm-panel half_rhythm\"></div><div class=\"fm-cpl-info fm-panel hide half_rhythm\" id=\"id864920_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a> : &#x000a9; Indian Journal of Medical and Paediatric Oncology</div><div class=\"fm-copyright half_rhythm\">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id=\"pmclinksbox\" class=\"links-box fm-panel whole_rhythm\"><div class=\"small\"><div>This article has been <a href=\"/pmc/articles/PMC3764732/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div id=\"__abstractid792568\" lang=\"en\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"__abstractid792568title\">Abstract</h2><!--article-meta--><div><p id=\"__p1\" class=\"p p-first-last\">Reporting a case, 53 years old male with stage IV Nonsamall cell lung cancer in view of cytologically proven malignant pleural effusion. Usually the management of stage IV lung cancer is with palliative intent where the patient receives palliative chemotherapy along with palliative radiotherapy and surgery if required. Most of the data on curative management of oligometastatic non-small cell lung cancer includes patient with adrenal metastasis and some reports with brain metastasis. There is scarce literature on the surgical management of stage IV lung cancer with pleural effusion.</p></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\"><em>Chemotherapy</em>, <em>cure</em>, <em>lung cancer</em>, <em>stage IV</em></span></div></div><div id=\"sec1-1\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-1title\">INTRODUCTION</h2><p id=\"__p2\" class=\"p p-first-last\">Lung cancer is one of the common differential diagnosis for, weight loss, lung mass, pleural effusion with lymphadenopathy in a male smoker in our country. The diagnosis requires high index of suspicion as it can be easily confused with tuberculosis and chronic bronchitis. The standard management of stage IV lung cancer with good performance status is palliative chemotherapy. Here we would like to discuss surgical options for oligometastic stage IV lung cancer with pleural effusion.</p></div><div id=\"sec1-2\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-2title\">CASE REPORT</h2><p id=\"__p3\" class=\"p p-first\">A 53-year-old male, chronic smoker, presented with history of left-sided dull aching chest pain for 1 month and significant weight loss of 5 kg in 1 month. There were no symptoms of breathing difficulty, hemoptysis, bony pains, or lumps noticed anywhere in body. Evaluation included a contrast-enhanced computed tomography (CT) of thorax which revealed a left upper lobe peripherally situated mass of size 2 &#x000d7; 2 cm involving chest wall, enlarged pretracheal, prevascular, and aortopulmonary window nodes, and mild left pleural effusion.</p><div id=\"sec2-1\" class=\"sec\"><h3>Differential diagnosis and diagnostic evaluation recommended</h3><p id=\"__p4\" class=\"p p-first\">The common differential diagnoses for weight loss and lung mass with lymphadenopathy in a male smoker in our country are chronic obstructive lung disease, chronic bronchitis, tuberculosis, pneumonia, and lung cancer. Clinical history and thorough examination should be made with careful palpation of the neck for lymphadenopathy and chest auscultation. A chest radiograph is the basis of imaging and is complemented by a contrast-enhanced CT scan of the chest, which should include the liver and the adrenal glands. Tissue diagnosis is mandatory if the clinicoradiological suspicion of malignancy is high and a biopsy should be performed either by bronchoscopy or with CT guidance. If confirmed to be malignant, further staging workup would be required if the chest CT scan shows non-metastatic disease. A metastatic workup would include a positron emission tomography (PET)-CT scan and a magnetic resonance imaging (MRI) scan of the brain.</p><p id=\"__p5\" class=\"p p-last\">Our patient presented to us with a CT scan showing a left upper lobe mass with ipsilateral mediastinal lymphadenopathy and a small pleural effusion. His vitals were normal, physical examination was unremarkable, and ECOG performance status was 1. Fiber optic bronchoscopy showed no endobronchial growth. Diagnostic thoracentesis was performed. Pleural fluid cytology was positive for metastatic squamous cell carcinoma.</p></div><div id=\"sec2-2\" class=\"sec sec-last\"><h3>Role of cytology in lung cancer</h3><p id=\"__p6\" class=\"p p-first\">Conventional cytologies such as sputum examination, bronchial lavage, bronchial brushings, fine-needle aspiration biopsy have played an important role in the diagnosis of primary and metastatic lung cancers. Immunohistochemical stains can be applied on cytological material. The immunohistochemical markers such as TTF-1, CK7, CK20, 4A4, 34 E12, and p63 help to classify further subtypes in Non-small cell lung cancer (NSCLC). In addition, epidermal growth factor receptor (EGFR) gene mutation studies can also be done on the blocks prepared from cytological material, which helps in choosing appropriate targeted therapy. Thus, cytology plays an important role not only to subclassify tumors but also to individualize treatment strategy with the advantage of easy availability and minimum invasiveness.[<a href=\"#ref1\" rid=\"ref1\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546175\">1</a>]</p><p id=\"__p7\" class=\"p p-last\">Thus, the patient was diagnosed with squamous cell carcinoma of the lung, T3N2M1a, stage IV.</p></div></div><div id=\"sec1-3\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-3title\">DISCUSSION OF MANAGEMENT</h2><p id=\"__p8\" class=\"p p-first\">The standard management of stage IV lung cancer is palliative chemotherapy with platinum-based combination chemotherapy. However, there are some reports of patients with lung cancer with only a malignant pleural effusion and no other metastatic sites that have long-term cures with chemotherapy and surgery.[<a href=\"#ref2\" rid=\"ref2\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546180\">2</a>,<a href=\"#ref3\" rid=\"ref3\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546195\">3</a>] In view of the excellent performance status of the patient and the PET-CT showing no other sites of metastases, it was decided that therapy with potentially curative intent could be attempted even though this would be a deviation from established guidelines. A staging workup was performed.</p><div id=\"sec2-3\" class=\"sec sec-last\"><h3>Staging evaluation of lung cancer</h3><p id=\"__p9\" class=\"p p-first\">After establishing a tissue diagnosis, a complete staging workup is done to identify the presence of metastasis and for feasibility of surgical resection.</p><p id=\"__p10\">After detailed history and physical examination, laboratory investigations such as complete blood count, liver function tests (transaminases), serum electrolytes, serum calcium, and serum alkaline phosphatase are done. More than 80% of patients with an abnormality on evaluation have metastatic disease. Patients presenting with anorexia, weight loss, and fatigue have an especially poor prognosis which depicts advanced stage and aggressive tumor biology.[<a href=\"#ref4\" rid=\"ref4\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546194\">4</a>]</p><p id=\"__p11\">Chest and abdomen CT and PET scans are routinely performed in patients with suspected metastatic lung cancer. Chest and upper abdomen CT scans help to identify hilar and mediastinal adenopathy and liver or adrenal metastases. CT chest has accuracy of 88% (80% sensitive and 100% specificity) in identifying mediastinal involvement. Integrated CT/PET has better sensitivity and specificity than CT or PET alone.[<a href=\"#ref5\" rid=\"ref5\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546197\">5</a>]</p><p id=\"__p12\" class=\"p p-last\">Bronchoscopy with or without transbronchial needle aspiration, endobronchial ultrasound-guided transbronchial needle aspiration, video-assisted thoracoscopy, or mediastinoscopy has played an important role in evaluation of patients with suspected mediastinal involvement. Video-assisted thoracoscopy or mediastinoscopy has the advantage of directly visualizing the lesion and accurate sampling. Additional investigations are performed depending on clinical symptoms. Bone scanning and brain magnetic resonance imaging may be performed, depending on symptoms.[<a href=\"#ref5\" rid=\"ref5\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546192\">5</a>]</p></div></div><div id=\"sec1-4\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-4title\">RADIOLOGICAL DISCUSSION (ROLE OF PET)</h2><p id=\"__p13\" class=\"p p-first\">PET/CT has good sensitivity and specificity in identifying distant metastases.[<a href=\"#ref6\" rid=\"ref6\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546189\">6</a>] Thus, the PET/CT is very important in the decision-making process for a patient with NSCLC, especially so in a patient with oligometastases. Any suspicious lesion identified by PET/CT should be confirmed by histopathological evaluation. Various studies have reported that whole body PET detects occult metastases in 6-17% of NSCLC patients in whom conventional staging methods failed to identify the metastases.[<a href=\"#ref7\" rid=\"ref7\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546176\">7</a>] PET/CT has positive predictive value of 54% in identifying additional lesions on top of the primary lung cancer.[<a href=\"#ref8\" rid=\"ref8\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546202\">8</a>]</p><p id=\"__p14\">A PET-CT scan and an MRI scan of the brain showed absence of metastatic disease. The patient was counseled in detail regarding the standard recommended treatment of palliative chemotherapy alone, or an off-guideline option of chemotherapy followed by surgery if the response was good. The patient chose the latter option. The patient was given three cycles of chemotherapy with gemcitabine 1000 mg/m<sup>2</sup> day 1 and day 8 along with carboplatin AUC 5 (area under the curve, calculated by Calvert formula) on day 1 for every 21 days. He tolerated the chemotherapy well without major side effects. There was significant symptomatic benefit in the pain after the first cycle of chemotherapy.</p><p id=\"__p15\">Following three cycles of chemotherapy, PET-CT revealed a 1.9 &#x000d7; 1.6 &#x000d7; 1.2 cm left lingular lobe mass (SUV 3.5) with no abnormal activity in the mediastinal nodes and no distant metastases. We performed a left upper lobectomy with systematic mediastinal lymphadenectomy following which the patient had an uneventful post-operative recovery. Intra-operatively, a 2 &#x000d7; 2 cm left upper lobe lung mass was seen adherent to the pericardium with enlarged aortopulmonary AP window and left hilar nodes. There were no pleural nodules or effusion. The final histopathology showed no residual tumor with all regional nodes negative for metastasis (ypT0N0) [<a href=\"/pmc/articles/PMC3764732/figure/F1/\" target=\"figure\" class=\"fig-table-link fig figpopup\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" co-legend-rid=\"lgnd_F1\"><span>Figure 1</span></a>].</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock ten_col whole_rhythm clearfix\" id=\"F1\" co-legend-rid=\"lgnd_F1\"><a class=\"icnblk_img figpopup\" href=\"/pmc/articles/PMC3764732/figure/F1/\" target=\"figure\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\"><img src=\"/pmc/articles/PMC3764732/bin/IJMPO-34-121-g001.gif\" class=\"small-thumb\" alt=\"Figure 1\" title=\"Figure 1\" src-large=\"/pmc/articles/PMC3764732/bin/IJMPO-34-121-g001.jpg\" /></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC3764732/figure/F1/\" target=\"figure\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\">Figure 1</a></div><!--caption a4--><div><span>Microscopy revealed large areas of necrosis, lymphoplasmacytic infiltrate, and hemosiderin deposits amidst areas of fibrosis. No residual tumor was identified (H and E, original magnification, &#x000d7;100)</span></div></div></div><p id=\"__p17\" class=\"p p-last\">The patient is now alive and free of disease after a 24-month follow-up.</p></div><div id=\"sec1-5\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-5title\">DISCUSSION OF PATHOLOGICAL RESPONSE</h2><p id=\"__p18\" class=\"p p-first\">Assessment of pathological response to chemotherapy has played an important role in head and neck carcinomas, esophageal carcinoma, osteogenic sarcoma, and small cell lung carcinoma. Pathological complete response is defined as fibrosis or fibro inflammation without microscopic evidence of carcinoma and histologically negative nodes. Non-pCR is defined as any evidence of viable carcinoma, either at the primary site or at the resected regional LN. Those patients who achieve complete pathological response have long-term survival advantage. Junker <em>et al</em>.[<a href=\"#ref9\" rid=\"ref9\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546170\">9</a>] found that in NSCLC patients, not only complete responders but also extensive responders with &#x0003c;10% residual tumor also had good long-term survival.</p><p id=\"__p19\">The common histological features of tumor regression are coagulative necrosis, fibrosis, foam cell/giant cell reaction, as well as mixed inflammatory infiltrate. The amounts of fibrosis correlate well with extent of tumor regression, which in turn is a surrogate marker of tumor response. Squamous carcinoma was associated with a higher probability of treatment response than adenocarcinoma.[<a href=\"#ref9\" rid=\"ref9\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546181\">9</a>]</p><p id=\"__p20\" class=\"p p-last\">To conclude, pathological response can be of two types: Responder and non-responder groups. The common histological changes seen are fibrosis, necrosis, and foam cell/giant cell reaction; in some cases, increase in residual tumor nuclear grade is seen. The radiological assessments may not correlate well with the pathological response.[<a href=\"#ref10\" rid=\"ref10\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546207\">10</a>]</p></div><div id=\"sec1-6\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-6title\">DISCUSSION OF MANAGEMENT OF STAGE IV NON-SMALL CELL LUNG CANCER</h2><p id=\"__p21\" class=\"p p-first\">NSCLC is the leading cause of cancer-related deaths worldwide. Brain, bone, liver, and adrenal gland are the most common extrapulmonary sites of distant metastases.[<a href=\"#ref11\" rid=\"ref11\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546201\">11</a>] 20-50% of NSCLC will present with metastatic disease. Stage IV NSCLC cancer has an overall median survival time of 7-11 months.[<a href=\"#ref12\" rid=\"ref12\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546186\">12</a>]</p><p id=\"__p22\">In the past, patients with stage IV disease were generally believed to be incurable. Patients with oligometastatic disease represent a distinct subset. After full evaluation, approximately 7% of patients with metastatic disease will have solitary metastasis.[<a href=\"#ref13\" rid=\"ref13\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546183\">13</a>,<a href=\"#ref14\" rid=\"ref14\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546185\">14</a>] There is evidence that in such patients, survival benefit can be achieved with surgical resection.[<a href=\"#ref15\" rid=\"ref15\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546196\">15</a>]</p><p id=\"__p23\">Accurate clinical staging is of utmost importance before embarking on curative surgery. FDG-PET/CT plays an important role in decision making and should be done if radical treatment is considered. The overall 5-year survival rate is about 28% for patients with satellite nodules and 21% for patients with ipsilateral pulmonary nodules. In patients with brain metastases, surgical resection achieves 5-year survival rates between 11% and 30%, and those with adrenalectomy for adrenal metastases have 5-year survival rates of 26%.[<a href=\"#ref15\" rid=\"ref15\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546203\">15</a>]</p><p id=\"__p24\" class=\"p\">Most of the data on curative management of oligometastatic NSCLC include patient with adrenal metastasis, brain metastasis, and few selected reports of patients with lung cancer with only a malignant pleural effusion and no other metastatic sites who have long-term cures with chemotherapy and surgery.[<a href=\"#ref2\" rid=\"ref2\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546171\">2</a>,<a href=\"#ref3\" rid=\"ref3\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546182\">3</a>]</p><div id=\"sec2-4\" class=\"sec\"><h3>Brain metastases</h3><p id=\"__p25\" class=\"p p-first\">Brain metastases have dismal prognosis without treatment, with median survival of 1-2 months.[<a href=\"#ref16\" rid=\"ref16\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546190\">16</a>] Historically, whole brain radiation therapy (WBRT) was the standard of care in the management of brain metastases. 75% of patients had symptomatic neurological improvement with WBRT alone. However, this benefit is short-lived, with a median survival of only 3-6 months. Chronic neurological morbidities were seen in significant patients on follow-up.[<a href=\"#ref17\" rid=\"ref17\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546173\">17</a>] With advances in surgical techniques, resection of solitary brain metastasis can be done with low surgical morbidity and mortality rates (0-3%).[<a href=\"#ref4\" rid=\"ref4\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546191\">4</a>]</p><p id=\"__p26\" class=\"p p-last\">Stereotactic radiosurgery is an alternative approach to surgical resection in which high dose of focused radiation in a single fraction to a specific intra-cranial target is delivered, thus minimizing the unwanted radiation exposure to normal surrounding parenchyma. Recent data suggest that the combined treatment regime is beneficial for patients with a single brain metastasis.[<a href=\"#ref18\" rid=\"ref18\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546188\">18</a>,<a href=\"#ref19\" rid=\"ref19\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546193\">19</a>]</p></div><div id=\"sec2-5\" class=\"sec\"><h3>Adrenal metastases</h3><p id=\"__p27\" class=\"p p-first-last\">The adrenal gland metastatic involvement ranges from 18% to 42% in an autopsy series.[<a href=\"#ref20\" rid=\"ref20\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546177\">20</a>,<a href=\"#ref21\" rid=\"ref21\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546199\">21</a>] Benign adenomas (2-9%) are common in general population, so the presence of an adrenal mass on imaging itself does not confirm metastasis.[<a href=\"#ref21\" rid=\"ref21\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546206\">21</a>,<a href=\"#ref22\" rid=\"ref22\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546204\">22</a>] The prognosis and management depend on whether the mass is benign or malignant. PET-CT and an MRI do not definitively rule out malignancy,[<a href=\"#ref22\" rid=\"ref22\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546169\">22</a>,<a href=\"#ref23\" rid=\"ref23\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546205\">23</a>] so histopathological confirmation is must before lung resection. The potential benefit of diagnostic laparoscopy over fine-needle biopsy alone is that it allows the exploration of the entire peritoneal cavity with a histological examination of suspected nodules.[<a href=\"#ref23\" rid=\"ref23\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546172\">23</a>,<a href=\"#ref24\" rid=\"ref24\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546187\">24</a>] Moreover, laparoscopic adrenalectomy done for diagnostic purposes is itself a therapeutic modality for metastases.[<a href=\"#ref24\" rid=\"ref24\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546184\">24</a>]</p></div><div id=\"sec2-6\" class=\"sec sec-last\"><h3>Other extrathoracic metastases</h3><p id=\"__p28\" class=\"p p-first-last\">In NSCLC, most common sites for oligometastatic disease include the thorax, adrenals, and brain; metastases other than these sites are rare. There are two retrospective case series addressing this issue.[<a href=\"#ref24\" rid=\"ref24\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546174\">24</a>,<a href=\"#ref13\" rid=\"ref13\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546198\">13</a>] Long-term survival was high, with a 5-year overall survival rate of 55.6% and a 10-year overall survival rate of 86% in reported series[<a href=\"#ref13\" rid=\"ref13\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546179\">13</a>,<a href=\"#ref25\" rid=\"ref25\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546178\">25</a>] Based on the above two retrospective studies, three factors are considered important in selecting patients for resection: (a) the primary tumor should be completely resected; (b) metastases must be metachronous onset; and (c) there should be no other distant metastasis.[<a href=\"#ref13\" rid=\"ref13\" class=\" bibr popnode tag_hotlink tag_tooltip\" id=\"__tag_331546200\">13</a>]</p></div></div><div id=\"sec1-7\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-7title\">SUMMARY</h2><p id=\"__p29\" class=\"p p-first-last\">Our patient was treated as stage IV NSCLC with curative intent as a deviation from established guidelines. In the absence of other distant metastases, he was given three cycles of neoadjuvant chemotherapy and underwent curative intent surgery. Complete pathological remission was achieved which has been rarely reported in literature.</p></div><div id=\"sec1-8\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"sec1-8title\">CONCLUSION</h2><p id=\"__p30\" class=\"p p-first-last\">The diagnosis of malignant pleural effusion with non-small cell carcinoma does not necessarily imply that patient has incurable disease. In selected subsets of patients, a cure may be possible after multimodality therapy. To properly select patients for an aggressive local treatment regime, accurate clinical staging is of prime importance. The use of FDG-PET should be considered for restaging if oligometastatic disease is suspected based on a patient's CT scan. Our case report illustrates the potential role of curative intent surgery in stage IV lung cancer, with malignant pleural effusion but without distant metastases. The usefulness of PET-CT imaging in the staging and evaluation of response are also highlighted by the current study.</p></div><div id=\"__fn-groupid796744\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"__fn-groupid796744title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"__fnid796745\"><p id=\"__p31\" class=\"p p-first-last\"><strong>Source of Support:</strong> Nil</p></p><p class=\"fn sec\" id=\"__fnid796755\"> <p id=\"__p32\" class=\"p p-first-last\"><strong>Conflict of Interest:</strong> None declared.</p></p></div></div><div id=\"__ref-listid796766\" class=\"tsec sec\"><h2 class=\"head no_bottom_margin\" id=\"__ref-listid796766title\">REFERENCES</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"ref1\">1. <span class=\"element-citation\">Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. <span><span class=\"ref-journal\">Mod Pathol. </span>2011;<span class=\"ref-vol\">24</span>:1348\u201359.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/21623384\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref2\">2. <span class=\"element-citation\">Mordant P, Arame A, Foucault C, Dujon A, Le Pimpec Barthes F, Riquet M. Surgery for metastatic pleural extension of non-small-cell lung cancer. <span><span class=\"ref-journal\">Eur J Cardiothorac Surg. </span>2011;<span class=\"ref-vol\">40</span>:1444\u20139.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/21515066\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref3\">3. <span class=\"element-citation\">Okamoto T, Iwata T, Mizobuchi T, Hoshino H, Moriya Y, Yoshida S, et al.  Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy. <span><span class=\"ref-journal\">Eur J Cardiothorac Surg. </span>2012;<span class=\"ref-vol\">41</span>:25\u201330.</span> <span class=\"nowrap ref pmc\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3241128/\">PMC free article</a>]</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/21616674\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref4\">4. <span class=\"element-citation\">Mussi A, Pistolesi M, Lucchi M, Janni A, Chella A, Parenti G, et al.  Resection of single brain metastasis in non-small-cell lung cancer: Prognostic factors. <span><span class=\"ref-journal\">J Thorac Cardiovasc Surg. </span>1996;<span class=\"ref-vol\">112</span>:146\u201353.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/8691861\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref5\">5. <span class=\"element-citation\">Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: Diagnosis and management. <span><span class=\"ref-journal\">Am Fam Physician. </span>2007;<span class=\"ref-vol\">75</span>:56\u201363.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/17225705\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref6\">6. <span class=\"element-citation\">Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, et al.  Adrenal lesions: Characterization with fused PET/CT image in patients with proved or suspected malignancy &#x02013; Initial experience. <span><span class=\"ref-journal\">Radiology. </span>2006;<span class=\"ref-vol\">238</span>:970\u20137.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/16505394\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref7\">7. <span class=\"element-citation\">Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM. Onko-PET der Deutschen Gesellschaft fur Nuklearmedizin. Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000. <span><span class=\"ref-journal\">Pneumologie. </span>2001;<span class=\"ref-vol\">55</span>:367\u201377.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/11505288\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref8\">8. <span class=\"element-citation\">Lardinois D, Weder W, Roudas M, von Schulthess GK, Tutic M, Moch H, et al.  Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. <span><span class=\"ref-journal\">J Clin Oncol. </span>2005;<span class=\"ref-vol\">23</span>:6846\u201353.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/16192576\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref9\">9. <span class=\"element-citation\">Junker K, Thomas M, Schulmann K, Klinke F, Bosse U, M&#x000fc;ller KM. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. <span><span class=\"ref-journal\">J Cancer Res Clin Oncol. </span>1997;<span class=\"ref-vol\">123</span>:469\u201377.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/9341895\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref10\">10. <span class=\"element-citation\">Junker K, Langner K, Klinke F, Bosse U, Thomas M. Grading of tumor regression in non-small cell lung cancer: Morphology and prognosis. <span><span class=\"ref-journal\">Chest. </span>2001;<span class=\"ref-vol\">120</span>:1584\u201391.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/11713138\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref11\">11. <span class=\"element-citation\">Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA, et al.  Distribution of distant metastases from newly diagnosed non-small cell lung cancer. <span><span class=\"ref-journal\">Ann Thorac Surg. </span>1996;<span class=\"ref-vol\">62</span>:246\u201350.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/8678651\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref12\">12. <span class=\"element-citation\">Ramalingam S, Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: Recent advances and future directions. <span><span class=\"ref-journal\">Oncologist. </span>2008;<span class=\"ref-vol\">13</span>:5\u201313.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/18263769\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref13\">13. <span class=\"element-citation\">Luketich JD, Martini N, Ginsberg RJ, Rigberg D, Burt ME. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. <span><span class=\"ref-journal\">Ann Thorac Surg. </span>1995;<span class=\"ref-vol\">60</span>:1609\u201311.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/8787451\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref14\">14. <span class=\"element-citation\">Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience. <span><span class=\"ref-journal\">J Clin Oncol. </span>1991;<span class=\"ref-vol\">9</span>:1618\u201326.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/1651993\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref15\">15. <span class=\"element-citation\">Pfannschmidt J, Dienemann H. Surgical treatment of oligometastatic non-small cell lung cancer. <span><span class=\"ref-journal\">Lung Cancer. </span>2010;<span class=\"ref-vol\">69</span>:251\u20138.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/20537426\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref16\">16. <span class=\"element-citation\">Richards P, Mckissock W. Intracranial metastases. <span><span class=\"ref-journal\">Br Med J. </span>1963;<span class=\"ref-vol\">1</span>:15\u20138.</span> <span class=\"nowrap ref pmc\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC2123114/\">PMC free article</a>]</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/13982100\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref17\">17. <span class=\"element-citation\">Deutsch M, Parsons JA, Mercado R., Jr Radiotherapy for intracranial metastases. <span><span class=\"ref-journal\">Cancer. </span>1974;<span class=\"ref-vol\">34</span>:1607\u201311.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/4473261\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref18\">18. <span class=\"element-citation\">Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. <span><span class=\"ref-journal\">Int J Radiat Oncol Biol Phys. </span>1999;<span class=\"ref-vol\">45</span>:427\u201334.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/10487566\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref19\">19. <span class=\"element-citation\">Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. <span><span class=\"ref-journal\">Lancet. </span>2004;<span class=\"ref-vol\">363</span>:1665\u201372.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/15158627\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref20\">20. <span class=\"element-citation\">Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. <span><span class=\"ref-journal\">Cancer. </span>1950;<span class=\"ref-vol\">3</span>:74\u201385.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/15405683\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref21\">21. <span class=\"element-citation\">McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. <span><span class=\"ref-journal\">AJR Am J Roentgenol. </span>1995;<span class=\"ref-vol\">165</span>:1453\u20139.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/7484585\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref22\">22. <span class=\"element-citation\">Kim HK, Choi YS, Kim K, Kim J, Shim YM. Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. <span><span class=\"ref-journal\">Lung Cancer. </span>2007;<span class=\"ref-vol\">58</span>:342\u20137.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/17825950\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref23\">23. <span class=\"element-citation\">Feliciotti F, Paganini AM, Guerrieri M, Baldarelli M, De Sanctis A, Campagnacci R, et al.  Laparoscopic anterior adrenalectomy for the treatment of adrenal metastases. <span><span class=\"ref-journal\">Surg Laparosc Endosc Percutan Tech. </span>2003;<span class=\"ref-vol\">13</span>:328\u201333.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/14571170\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref24\">24. <span class=\"element-citation\">Ambrogi V, Tonini G, Mineo TC. Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer. <span><span class=\"ref-journal\">Ann Surg Oncol. </span>2001;<span class=\"ref-vol\">8</span>:663\u20136.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/11569782\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"ref25\">25. <span class=\"element-citation\">Hishida T, Nagai K, Yoshida J, Nishimura M, Ishii G, Iwasaki M, et al.  Is surgical resection indicated for a solitary non-small cell lung cancer recurrence? <span><span class=\"ref-journal\">J Thorac Cardiovasc Surg. </span>2006;<span class=\"ref-vol\">131</span>:838\u201342.</span>  <span class=\"nowrap ref pubmed\">[<a href=\"/pubmed/16580442\" target=\"pmc_ext\" ref=\"reftype=pubmed&amp;article-id=3764732&amp;issue-id=227223&amp;journal-id=1247&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal\">PubMed</a>]</span></span></div></div></div></div><!--post-content--><hr class=\"whole_rhythm no_bottom_margin\" /><div class=\"courtesy-note no_margin small\">Articles from <span class=\"acknowledgment-journal-title\">Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical &#x0026; Paediatric Oncology</span> are provided here courtesy of <strong>Medknow Publications</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id=\"rightcolumn\" class=\"four_col col last\">\n        <!-- Custom content above discovery portlets -->\n        <div class=\"col6\">\n            \n        </div>\n        \n        <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC3764732/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC3764732/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC3764732/?report=printable\">Printer Friendly</a></li> | <li><a href=\"#\" data-citationid=\"PMC3764732\" class=\"citationexporter ctxp\">Citation</a></li></ul></div></div><div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" class=\"share-buttons\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3764732%2F\"><img src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/img/4047626\" alt=\"Share on Facebook\" />\n                             Facebook\n                        </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3764732%2F&amp;text=Stage%20IV%20lung%20cancer%3A%20Is%20cure%20possible%3F\"><img src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/img/4047627\" alt=\"Share on Twitter\" />\n                             Twitter\n                        </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3764732%2F\"><img src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/img/4047628\" alt=\"Share on Google Plus\" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id=\"ajax-portlets\" data-pmid=\"24049303\" data-aiid=\"3764732\" data-aid=\"3764732\" data-iid=\"227223\" data-domainid=\"1247\" data-domain=\"ijmedpaed\" data-accid=\"PMC3764732\" data-md5=\"dbce206a50ad81d1b0cee65a3d71fd96\"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class=\"col7\">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class=\"col8\">\n    \n</div>\n<div class=\"col9\">\n    \n</div>\n\n<script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n<script>\n    (function($){\n        $('.skiplink').each(function(i, item){\n            var href = $($(item).attr('href'));\n            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n            $(item).on('click', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id=\"body-link-poppers\"></div>\n                        </div>\n                        <div class=\"bottom\">\n                            \n                            <div id=\"NCBIFooter_dynamic\">\n    <div class=\"breadcrumbs\">You are here: \n            <span id=\"breadcrumb_text\"><a href=\"/guide/\">NCBI</a> &gt; <a href=\"https://www.ncbi.nlm.nih.gov/guide/literature/\">Literature</a> &gt; <a href=\"https://www.ncbi.nlm.nih.gov/pmc/\">PubMed Central (PMC)</a></span></div>\n    <a id=\"help-desk-link\" class=\"help_desk jig-ncbihelpwindow\" target=\"_blank\" href=\"/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.39&amp;Time=2016-11-06T10:35:43-05:00&amp;Host=ptpmc101\">Write to the Help Desk</a>\n    \n</div>\n\n                            <div class=\"footer\" id=\"footer\">\n    \n    <div class=\"subfooter\"> </div><script type=\"text/javascript\" src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\"> </script>\n    <div id=\"external-disclaimer\" class=\"offscreen_noflow\">\n        External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n    </div>    \n    <div id=\"ncbifooter\" class=\"contact_info\">      \n        <div id=\"footer-contents-right\">\n            <div id=\"nlm_thumb_logo\">\n                <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n            </div>\n            <div id=\"nih_thumb_logo\">\n                <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n            </div>\n            <div id=\"hhs_thumb_logo\">\n                <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n            </div>\n            <div id=\"usagov_thumb_logo\">\n                <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id=\"footer-contents-left\">\n            <p class=\"address vcard\">\n                <span class=\"url\">\n                    <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n                <span class=\"adr\">\n                    <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n                    <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n                    <span class=\"country-name\">USA</span>\n                </span>\n            </p>\n            \n            <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n        </div>\n    </div>\n    <script type=\"text/javascript\" src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\"> </script>    \n    <script type=\"text/javascript\" src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class=\"PAFAppResources\"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt=\"statistics\" src=\"/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=ijmedpaed&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3764732/&amp;ncbi_app=pmc\" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id=\"PageFixtures\" label=\"styles\"></component>-->\n    \n\n<!-- 8A1A37C181F4DCE1_0095SID /projects/PMC/PMCViewer@4.39 ptpmc101 v4.1.r508797 Mon, Aug 01 2016 12:51:16 -->\n\n<script type=\"text/javascript\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4132802/js/3879255/4121861/3818874/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js\" snapshot=\"pmc\"></script></body>\n</html>"}